Raza A, Kuliczkowski K, Weidong G, Preisler H D
Med Oncol Tumor Pharmacother. 1984;1(3):163-8.
The kinetics of cytosine arabinoside (AraC) were studied in vitro using P388 murine leukemia lines sensitive (P388-S) and resistant (P388-R) to the drug. Using P388-S cells, the 3H-thymidine index (L.I.) was paralleled by the 3H-AraC index, i.e. any cell in the S-phase of the cycle also incorporated the 3H-AraC into DNA. With the resistant line, the 3H-AraC index was zero in spite of high L.I. This discrepancy between the L.I. and 3H-AraC index could be used to predict the percentage of resistant cells when known mixtures of sensitive and resistant populations were used. The reason for lack of incorporation into DNA by the resistant cells was shown to be the presence of very low levels of the enzyme deoxycytidine kinase in P388-R cells resulting in an inability to phosphorylate AraC to its active form AraCTP. Immediate inhibition of DNA synthesis caused by AraC was directly proportional to the number of sensitive cells present in the population, but was not as accurate a predictor of sensitivity as the 3H-AraC index. Cloning in methylcellulose was found to be the least sensitive predictor of the percentage of sensitive and resistant cells, most likely related to the difference in cloning efficiency of the sensitive and resistant lines.
利用对阿糖胞苷(AraC)敏感(P388-S)和耐药(P388-R)的P388小鼠白血病细胞系,在体外研究了阿糖胞苷的动力学。对于P388-S细胞,3H-胸腺嘧啶核苷指数(L.I.)与3H-AraC指数平行,即处于细胞周期S期的任何细胞也将3H-AraC掺入DNA。对于耐药细胞系,尽管L.I.较高,但3H-AraC指数为零。当使用已知的敏感和耐药群体混合物时,L.I.与3H-AraC指数之间的这种差异可用于预测耐药细胞的百分比。结果表明,耐药细胞不能将其掺入DNA的原因是P388-R细胞中脱氧胞苷激酶的水平非常低,导致无法将AraC磷酸化为其活性形式AraCTP。AraC对DNA合成的即时抑制与群体中存在的敏感细胞数量成正比,但作为敏感性的预测指标不如3H-AraC指数准确。发现甲基纤维素克隆是对敏感和耐药细胞百分比最不敏感的预测指标,这很可能与敏感和耐药细胞系克隆效率的差异有关。